AGENUS INC

Profile

Company Names

AGENUS INC
ANTIGENICS INC /DE/

Addresses

3 FORBES ROAD, LEXINGTON, MA 02421

Phone Numbers

781-674-4400

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$221,182,743.00

Number of Funding Rounds:

11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2019-01-23 
$30,000,000.00 
$30,000,000.00 
$0.00 
Equity 
10
2018-10-11 
$40,000,653.00 
$40,000,653.00 
$0.00 
Equity 
9
2017-02-14 
$60,000,000.00 
$60,000,000.00 
$0.00 
Equity 
8
2015-12-31 
$500,000.00 
$500,000.00 
$0.00 
Equity 
7
2015-12-23 
$7,400,090.00 
$42,400,090.00 
$35,000,000.00 
Equity 
6
2015-09-08 
$2,142,000.00 
$2,142,000.00 
$0.00 
Equity 
5
2015-02-20 
$21,140,000.00 
$21,140,000.00 
$0.00 
Debt 
4
2015-02-18 
$35,000,000.00 
$35,000,000.00 
$0.00 
Equity 
3
2013-04-15 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
2
2009-08-04 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
1
2009-08-03 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GARO 
 
ARMEN 
EXECUTIVE OFFICER, DIRECTOR
PROTAGENIC THERAPEUTICS INC   |  AGENUS INC   |  PROTAGENIC THERAPEUTICS INC.
GARO 
H 
ARMEN 
EXECUTIVE OFFICER, DIRECTOR
ANTIGENICS INC /DE/   |  PROTAGENIC THERAPEUTICS, INC.\NEW
GARO 
H. 
ARMEN 
EXECUTIVE OFFICER, DIRECTOR
ANTIGENICS INC /DE/   |  AGENUS INC   |  ANTIGENICS LLC/DE   |  ATRINSIC, INC.
CHARLES 
EVAN 
BALLANTYNE 
EXECUTIVE OFFICER
AGENUS INC   |  ANTIGENICS LLC/DE
OZER 
 
BAYSAL 
EXECUTIVE OFFICER
AGENUS INC
JENNIFER 
 
BUELL 
EXECUTIVE OFFICER
AGENUS INC
CHRISTIAN 
 
CORTIS 
EXECUTIVE OFFICER
AGENUS INC   |  TECTONIC THERAPEUTIC, INC.
BRIAN 
 
CORVESE 
DIRECTOR
ANTIGENICS INC /DE/   |  AGENUS INC
TOM 
 
DECHAENE 
DIRECTOR
ANTIGENICS INC /DE/   |  AGENUS INC
ALEX 
 
DUNCAN 
EXECUTIVE OFFICER
AGENUS INC
JOHN 
 
HATSOPOULOS 
DIRECTOR
ANTIGENICS INC /DE/
ALLISON 
 
JEYNES-ELLIS 
DIRECTOR
AGENUS INC
WADIH 
 
JORDAN 
DIRECTOR
ANTIGENICS INC /DE/   |  AGENUS INC
EVAN 
 
KEARNS 
EXECUTIVE OFFICER
AGENUS INC
CHRISTINE 
 
KLASKIN 
EXECUTIVE OFFICER
AGENUS INC
CHRISTINE 
M 
KLASKIN 
EXECUTIVE OFFICER
ANTIGENICS INC /DE/   |  AMERICAN DG ENERGY INC
CHRISTINE 
M. 
KLASKIN 
EXECUTIVE OFFICER
AMERICAN DG ENERGY INC   |  AGENUS INC
HYAM 
I 
LEVITSKY, M. D. 
DIRECTOR
ANTIGENICS INC /DE/
HYAM 
I 
LEVITSKY, M.D 
DIRECTOR
ANTIGENICS INC /DE/
SHAHZAD 
 
MALIK 
DIRECTOR
CONATUS PHARMACEUTICALS INC   |  PATHWORK DIAGNOSTICS INC   |  VERSARTIS, INC.   |  ACUTUS MEDICAL, INC.   |  IDUN PHARMACEUTICALS INC   |  ADVENT LIFE SCIENCES FUND II LP   |  AGENUS INC   |  NALU MEDICAL, INC.   |  AXONICS MODULATION TECHNOLOGIES, INC.   |  ITERUM THERAPEUTICS LTD   |  ADVENT LIFE SCIENCES FUND III LP   |  ITERUM THERAPEUTICS BERMUDA LTD   |  ITERUM THERAPEUTICS PLC   |  ITERUM THERAPEUTICS US LTD   |  ITERUM THERAPEUTICS US HOLDING LTD   |  ITERUM THERAPEUTICS INTERNATIONAL LTD   |  ADVENT-HARRINGTON IMPACT FUND LP   |  MOXIMED, INC   |  ADVENT LIFE SCIENCES GROWTH FUND LP
TIMOTHY 
 
ROTHWELL 
DIRECTOR
ANTIGENICS INC /DE/   |  EMISPHERE TECHNOLOGIES INC
SHALINI 
 
SHARP 
DIRECTOR, EXECUTIVE OFFICER
ANTIGENICS INC /DE/   |  ULTRAGENYX PHARMACEUTICAL INC.   |  AGENUS INC   |  PRECISION BIOSCIENCES INC   |  MAHZI THERAPEUTICS INC.   |  IAMBIC THERAPEUTICS, INC.
ROBERT 
 
STEIN 
EXECUTIVE OFFICER
PROGRESSIVE BOOK CLUB LLC   |  AGENUS INC   |  ASSURANT INC   |  REACTIVECORE, INC.   |  FLAME BIOSCIENCES, INC.   |  IMMUNOGENESIS, INC.   |  ALPHEUS MEDICAL, INC.
ROBERT 
B. 
STEIN 
EXECUTIVE OFFICER
KINEMED INC   |  ATRINSIC, INC.   |  AGENUS INC   |  IMMUNOGENESIS, INC.
KAREN 
 
VALENTINE 
EXECUTIVE OFFICER
ANTIGENICS INC /DE/   |  AGENUS INC   |  CONSTELLATION PHARMACEUTICALS INC
KAREN 
H. 
VALENTINE 
EXECUTIVE OFFICER
AGENUS INC   |  ANTIGENICS LLC/DE
KERRY 
 
WENTWORTH 
EXECUTIVE OFFICER
AGENUS INC
KERRY 
A 
WENTWORTH 
EXECUTIVE OFFICER
ANTIGENICS INC /DE/
ULF 
 
WIINBERG 
DIRECTOR
AGENUS INC   |  X-VAX TECHNOLOGY, INC.
TIMOTHY 
 
WRIGHT 
DIRECTOR
ANTIGENICS INC /DE/   |  NEXAGE, INC.   |  AGENUS INC   |  SCHRODINGER, INC.   |  APIFIA INC.   |  DISRUPTOR BEAM, INC.   |  BOSTON ILLIQUID SECURITIES OFFERING NETWORK, INC.   |  ARCHIPELAGO ANALYTICS HOLDINGS, INC.   |  BEAMABLE, INC.
TIMOTHY 
R. 
WRIGHT 
DIRECTOR
AGENUS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-02-01
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-01-23 
2018-10-25
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-10-11 
2017-03-01
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2017-02-14 
2016-01-08
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-12-31 
2016-01-04
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-12-23 
2015-09-23
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-09-08 
2015-03-05
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-02-18 
2015-03-05
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2015-02-20 
2013-04-25
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2013-04-15 
2009-08-13
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2009-08-03 
2009-08-13
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2009-08-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
RODMAN + RENSHAW, LLC
16415
RODMAN + RENSHAW, LLC
16415